Q2 2016 13F Holders as of 30 Jun 2016
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
67,113,783
-
Share change
-
-27,851,334
-
Total reported value
-
$28,852,000
-
Put/Call ratio
-
600%
-
Price per share
-
$0.43
-
Number of holders
-
59
-
Value change
-
-$14,814,454
-
Number of buys
-
17
-
Number of sells
-
63
Institutional Holders of OREXIGEN THERAPEUTICS INC - COM (OREX) as of Q2 2016
As of 30 Jun 2016,
OREXIGEN THERAPEUTICS INC - COM (OREX) was held by
59 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
67,113,783 shares.
The largest 10 holders included
BAUPOST GROUP LLC/MA, SAMLYN CAPITAL, LLC, Foresite Capital Management II, LLC, BVF INC/IL, VANGUARD GROUP INC, MORGAN STANLEY, Foresite Capital Management III, LLC, BlackRock Institutional Trust Company, N.A., BlackRock Fund Advisors, and Palo Alto Investors, LLC.
This page lists
59
institutional shareholders reporting positions in this security
for the Q2 2016 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.